OncoTherapy Science, Inc. Logo

OncoTherapy Science, Inc.

Develops targeted cancer therapies and provides TCR repertoire analysis services.

4564 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
川崎市川崎区東田町1番地2
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

OncoTherapy Science, Inc. is a biotechnology company focused on the research and development of novel cancer treatments. Founded in 2001, the company collaborates with genomics pioneer Professor Yusuke Nakamura to identify cancer-specific genes for the creation of molecular-targeted therapies, including low-molecular-weight drugs and antibody drugs. The company's mission is to develop treatments with high efficacy and minimal adverse events. In addition to its drug discovery pipeline, OncoTherapy Science offers a comprehensive T-cell receptor (TCR) repertoire analysis service, utilizing next-generation sequencing technology for detailed immunoprofiling from blood and tissue samples.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for OncoTherapy Science, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-26 03:49
Regulatory News Service
臨時報告書
Japanese 21.9 KB
2025-06-24 09:11
Regulatory News Service
内部統制報告書-第24期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-24 09:10
Regulatory News Service
確認書
Japanese 8.2 KB
2025-06-24 09:09
Annual Report
有価証券報告書-第24期(2024/04/01-2025/03/31)
Japanese 976.0 KB
2025-04-10 08:33
Prospectus
有価証券届出書(組込方式)
Japanese 404.8 KB
2025-02-18 01:06
Regulatory News Service
臨時報告書
Japanese 21.4 KB
2024-11-11 01:25
Regulatory News Service
確認書
Japanese 8.1 KB
2024-11-11 01:23
Interim Report
半期報告書-第24期(2024/04/01-2025/03/31)
Japanese 272.5 KB
2024-06-28 08:58
Regulatory News Service
臨時報告書
Japanese 22.8 KB
2024-06-25 09:30
Regulatory News Service
内部統制報告書-第23期(2023/04/01-2024/03/31)
Japanese 22.9 KB
2024-06-25 09:29
Regulatory News Service
確認書
Japanese 8.2 KB
2024-06-25 09:26
Annual Report
有価証券報告書-第23期(2023/04/01-2024/03/31)
Japanese 1007.8 KB
2024-04-05 08:07
Prospectus
有価証券届出書(組込方式)
Japanese 368.3 KB
2024-02-16 08:53
Regulatory News Service
臨時報告書
Japanese 22.1 KB
2024-02-13 01:17
Regulatory News Service
確認書
Japanese 8.2 KB

Automate Your Workflow. Get a real-time feed of all OncoTherapy Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OncoTherapy Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hit Co., Ltd. Logo
Specialized OOH advertising firm providing digital & static billboards in high-visibility areas.
Japan 378A
HONYAKU Center Inc. Logo
Provides industrial translation and interpreting for patent, legal, and corporate clients.
Japan 2483
Human Metabolome Technologies, Inc. Logo
A leader in metabolomics, providing CE-MS analysis to support R&D in biotech, pharma, and food.
Japan 6090
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France ALHYG
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan 3970
INTAGE HOLDINGS Inc. Logo
Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.
Japan 4326

Talk to a Data Expert

Have a question? We'll get back to you promptly.